GB-115

DB19204InvestigationalSmall molecule

GB-115 is under investigation in clinical trial NCT05586789 (A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders).

Mechanism: Pharmacologically active on Gastrin/cholecystokinin type B receptor
Curator reviewed
Formula / weight: C₂₅H₃₀N₄O₃ · 434.54 g/mol (avg)
Also known as: L-tryptophanamide, n-(1-oxo-6-phenylhexyl)glycyl- · N-(1-oxo-6-phenylhexyl)glycyl-l-tryptophanamide
Code names: (-)-GB-115

Resolves to

Compound

UNIIG5YT2F7SG8CAS678996-63-9

Structure

InChIKeyZBIQNIJICMOVKN-QFIPXVFZSA-NSMILESNC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)CNC(=O)CCCCCC1=CC=CC=C1

Targets

P32239CCKBR

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with GB-115, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account